TCL Archive ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies June 5, 2009
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive In Congress: Time Running out On Effort To Double Market Exclusivity Term November 7, 1997